ESG Report

Overview

The report describes Starpharma's FY23 group-wide ESG practices across environment, people, products and patient health, and governance. It reports estimated water consumption of 553 kilolitres and Scope 1 and 2 emissions of 17.2 and 384.5 t.CO2-e, respectively. Women represented 51% of employees, 52% of leadership/management and 34% of directors. The report also states that it was not subject to external audit and that the Board oversees climate-related matters.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2023
Period: Ends 30 June 2023
Language: English
Pages
File size

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services